CongressBuys

Sen. John Hoeven sold Johnson & Johnson (JNJ)

Sen. John Hoeven (R-ND) · $100K–$250K · traded Jan 20, 2017

Transaction
Sold (full)
Amount
$100K–$250K
Owner
The member
Traded
Jan 20, 2017
Disclosed
Jan 25, 2017
Days to disclose
5
Asset type
Stock
As filed
Johnson & Johnson
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

Recent Congress trades in JNJ

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.